Forum to focus on Innovative Partnership Opportunities for Product, Porfolio and Market Development
Read moreMulti-Center Phase III trial planned for 2019
Read moreLink to the interview of Eastgate's CEO Ms. Anna Gluskin.
Read moreFollowing a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day
Read moreEastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin
Read moreInterview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)
Read moreAlliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse
Read moreEastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre
Read moreEastgate Biotech Corp.appointed key consultants Saul A. Mashaal, PhmB, MBA and Munaf Ali, PhD to assist in regulatory matters and manufacturing of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients.
Read moreEastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives
Read more